Thymosin α1: An endogenous regulator of inflammation, immunity, and tolerance

Annals of the New York Academy of Sciences

Volumn 1112, Issue , 2007, Pages 326-338

  Romani, Luigina ^a   Bistoni, Francesco ^a   Montagnoli, Claudia ^a   Gaziano, Roberta ^b   Bozza, Silvia ^b   Bonifazi, Pierluigi ^a   Zelante, Teresa ^a   Moretti, Silvia ^a   Rasi, Guido ^c   Garaci, Enrico ^b   Puccetti, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c CNR   (Italy)

Author keywords

Dendritic cells; Immunity and tolerance; Regulatory T cells; Thymosin; Toll like receptors

Indexed keywords

ALPHA INTERFERON; AMPHOTERICIN B; ANTIGEN; GAMMA INTERFERON; GANCICLOVIR; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON REGULATORY FACTOR 7; MYELOID DIFFERENTIATION FACTOR 88; PROTHYMOSIN ALPHA; THYMOSIN ALPHA1; TOLL LIKE RECEPTOR; DRUG DERIVATIVE; THYMOSIN;

ALLERGIC DISEASE; ALLERGY; ALLOGENIC BONE MARROW TRANSPLANTATION; AMINO ACID METABOLISM; ANTIFUNGAL ACTIVITY; ANTIGEN RECOGNITION; ANTIVIRAL ACTIVITY; ASPERGILLOSIS; CANCER; CATABOLISM; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INDUCTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMEOSTASIS; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; IMMUNOTOXICITY; INFECTION; INFLAMMATION; INTERFERON PRODUCTION; MAMMAL; NONHUMAN; PNEUMONIA; PROTEIN DEGRADATION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TRANSPLANTATION TOLERANCE; VIRUS INFECTION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERSENSITIVITY; IMMUNOLOGY; INNATE IMMUNITY; MYCOSIS; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TH1 CELL; THYMUS;

MAMMALIA; MURID HERPESVIRUS 1;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ASPERGILLOSIS; DENDRITIC CELLS; HIV INFECTIONS; HOMEOSTASIS; HUMANS; HYPERSENSITIVITY; IMMUNITY, NATURAL; INFLAMMATION; MYCOSES; NEOPLASMS; SIGNAL TRANSDUCTION; TH1 CELLS; THYMOSIN; THYMUS GLAND;

EID: 35349015651     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1415.002     Document Type: Conference Paper

References (29)

1. MEDZHITOV, R. & C.A. JANEWAY, JR. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300.
2. AKIRA, S., K. TAKEDA & T. KAISHO. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680.
3. SCHNARE, M. et al. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2: 947-950.
4. COOK, D.N., D.S. PISETSKY & D.A. SCHWARTZ. 2004. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5: 975-979.
5. KABELITZ, D., D. WESCH & H.H. OBERG. 2006. Regulation of regulatory T cells: role of dendritic cells and toll-like receptors. Crit. Rev. Immunol. 26: 291-306.
6. SAKAGUCHI, S. 2004. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
7. CHEN, W. 2006. Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance. Front Biosci. 11: 1360-1370.
8. GOLDSTEIN, A.L. et al. 1972. Purification and biological activity of thymosin, a hormone of the thymus gland. Proc. Natl. Acad. Sci. USA 69: 1800-1803.
9. GOLDSTEIN, A.L. & M. BADAMCHIAN. 2004. Thymosins: chemistry and biological properties in health and disease. Expert Opin. Biol. Ther. 4: 559-573.
10. SODHI, A. & S. PAUL. 2002. Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha 1. Int. Immunopharmacol. 2: 47-58.
11. STEINMAN, R.M., D. HAWIGER & M.C. NUSSENZWEIG. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
12. WATTS, C. et al. 2007. Proximal effects of Toll-like receptor activation in dendritic cells. Curr. Opin. Immunol. 19: 73-78.
13. ROMANI, L. et al. 2004. Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood 103: 4232-4239.
14. PATTERSON, T.F. et al. 2000. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Balt.) 79: 250-260.
15. BOZZA, S. et al. 2003. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 102: 3807-3814.
16. BOZZA, S. et al. 2002. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J. Immunol. 168: 1362-1371.
17. GANDHI, M.K. & R. KHANNA. 2004. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect. Dis. 4: 725-738.
18. BEUTLER, B. et al. 2005. Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model. Curr. Opin. Immunol. 17: 36-43.
19. ANDREWS, D.M. et al. 2005. Cross-talk between dendritic cells and natural killer cells in viral infection. Mol. Immunol. 42: 547-555.
20. BOZZA, S. et al. 2007. Thymosin a 1 activates the TLR9/MyD88/IRF7-dependent murine Cytomegalovirus sensing for induction of antiviral responses in vivo. Int. Immunol. In press.
21. GROHMANN, U., F. FALLARINO & P. PUCCETTI. 2003. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24: 242-248.
22. MELLOR, A.L. & D.H. MUNN. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774.
23. FALLARINO, F. & P. PUCCETTI. 2005. Toll-like receptor 9-mediated induction of the immunosuppressive pathway of tryptophan catabolism. Eur. J. Immunol. 36: 8-11.
24. ORABONA, C. et al. 2006. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 107: 2846-2854.
25. ROMANI, L. et al. 2006. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 108: 2265-2274.
26. MOSEMAN, E.A. et al. 2004. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 173: 4433-4442.
27. UMETSU, D.T. et al. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3: 715-720.
28. MONTAGNOLI, C. et al. 2006. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol. 176: 1712-1723.
29. JIANG, S. & R.I. LECHLER. 2006. CD4 + CD25 + regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection. Inflamm. Allergy Drug Targets 5: 239-242.